| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/0115426506021002155 © 2006 The American Society for Parenteral and Enteral Nutrition
Nutrition Modulation of Cachexia/Proteolysis![]() ![]() ![]()
* Methodist Research Institute of Clarian Health
Partners, Indianapolis, Indiana; and the Correspondence: Gary P. Zaloga, MD, Medical Director, Methodist Research Institute, 1812 N Capitol Ave, Wile Hall, Room 120, Indianapolis, IN 46202. Electronic mail may be sent to gzaloga{at}clarian.org.
Cachexia represents progressive wasting of muscle and adipose tissue and is
associated with increased morbidity and mortality. Although anorexia usually
accompanies cachexia, cachexia rarely responds to increased food intake alone.
Our knowledge of the underlying mechanisms responsible for cachexia remains
incomplete. However, most states of cachexia are associated with underlying
inflammatory processes and/or cancer. These processes activate protein
degradation and lipolytic pathways, resulting in tissue loss. In this article,
we briefly review the pathophysiology of cachexia and discuss the role of
specific nutrient supplements for the treatment of cachexia. The branched
chain amino acid leucine, the leucine metabolite
β-hydroxy-β-methylbutyrate, arginine, glutamine,
This article has been cited by other articles:
|
|||||||||||||

-3 long
chain fatty acids, conjugated linoleic acid, and polyphenols have demonstrated
some efficacy in animal and/or human studies. Optimal treatment for cachexia
is likely aimed at maximizing muscle and adipose synthesis while minimizing
degradation. 